Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Researchers develop technique to track proteins on the surfaces of endoplasmic reticulum in cells

Researchers develop technique to track proteins on the surfaces of endoplasmic reticulum in cells

Cancer patients share survivorship story, celebrate strength and self-care

Cancer patients share survivorship story, celebrate strength and self-care

Vitamin D metabolite may stop mechanism by which cancer cells become drug-resistant

Vitamin D metabolite may stop mechanism by which cancer cells become drug-resistant

Community pharmacies can help improve physical activity and diet of men with prostate cancer

Community pharmacies can help improve physical activity and diet of men with prostate cancer

UCLA physicians find more effective method for detecting prostate cancer

UCLA physicians find more effective method for detecting prostate cancer

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

High levels of abdominal and thigh fat linked with increased risk of aggressive prostate cancer

High levels of abdominal and thigh fat linked with increased risk of aggressive prostate cancer

Researchers find more effective way to treat drug-resistant cancers

Researchers find more effective way to treat drug-resistant cancers

Novel radiotracer can identify nearly 30 types of malignant tumors

Novel radiotracer can identify nearly 30 types of malignant tumors

World’s first clinical guidance on anal sex after prostate cancer treatments

World’s first clinical guidance on anal sex after prostate cancer treatments

Prostate cancer diagnosis gets a boost from MRI

Prostate cancer diagnosis gets a boost from MRI

International clinical study of new drug to treat advanced prostate cancers yields promising results

International clinical study of new drug to treat advanced prostate cancers yields promising results

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

Researchers describe how prostate cancer cells develop ability to mimic osteoblasts

Researchers describe how prostate cancer cells develop ability to mimic osteoblasts

Prostate cancer marker activates growth factors that contribute to tumor spread

Prostate cancer marker activates growth factors that contribute to tumor spread

New technology helps reduce cost and time needed to do common laboratory tests

New technology helps reduce cost and time needed to do common laboratory tests

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

Inhibition of protein may prevent spread of castration-resistant prostate cancer

Inhibition of protein may prevent spread of castration-resistant prostate cancer

Researchers examine the protocol for treating aggressive prostate cancer

Researchers examine the protocol for treating aggressive prostate cancer